TRELEGY ELLIPTA is a prescription medication designed for the maintenance treatment of individuals with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and is also used to treat asthma in adults. This inhalation powder combines three active ingredients: fluticasone furoate, an inhaled corticosteroid (ICS) that reduces inflammation in the lungs; umeclidinium, a long-acting muscarinic antagonist (LAMA) that helps to relax and open up the airways; and vilanterol, a long-acting beta2-adrenergic agonist (LABA) that also helps to keep the airways open. TRELEGY ELLIPTA is designed for once-daily use, providing a convenient option for patients looking to manage their respiratory conditions with a single inhaler. It is important to note that this medication is not intended for the relief of acute bronchospasm or as a first treatment for asthma since it requires a diagnosis of COPD or severe asthma that is not adequately controlled with other medications.
When using TRELEGY ELLIPTA, it's crucial to adhere strictly to your doctor's instructions and thoroughly read the label that accompanies the medication. This inhaler, used for managing COPD and asthma, can have side effects that may impact your daily activities, including driving. Common side effects include headaches, cold symptoms, and cough, while rarer ones might involve changes in blood pressure, heart rate, and vision disturbances. It's essential to be cautious if you experience dizziness or blurred vision, as these could impair your ability to drive or operate machinery safely. Always inform your doctor about any other medications you're taking to avoid potentially harmful interactions. Remember, the key to minimizing risks and maximizing benefits is open communication with your healthcare provider and strict adherence to their guidance.